These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28690202)

  • 1. The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro.
    Bartl J; Palazzesi F; Parrinello M; Hommers L; Riederer P; Walitza S; Grünblatt E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):281-288. PubMed ID: 28690202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.
    Heal DJ; Pierce DM
    CNS Drugs; 2006; 20(9):713-38. PubMed ID: 16953648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter?
    Markowitz JS; Patrick KS
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S54-61. PubMed ID: 18480678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study.
    Markowitz JS; DeVane CL; Pestreich LK; Patrick KS; Muniz R
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):687-98. PubMed ID: 17201613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of the enantiomers of threo-methylphenidate.
    Patrick KS; Caldwell RW; Ferris RM; Breese GR
    J Pharmacol Exp Ther; 1987 Apr; 241(1):152-8. PubMed ID: 3572779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does chirality matter? pharmacodynamics of enantiomers of methylphenidate in patients with attention-deficit/hyperactivity disorder.
    Quinn D
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S62-6. PubMed ID: 18480679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats.
    Slezak JM; Ricaurte GA; Tallarida RJ; Katz JL
    Psychopharmacology (Berl); 2014 Jan; 231(1):191-8. PubMed ID: 23975034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicokinetic assessment of methylphenidate (Ritalin) enantiomers in pregnant rats and rabbits.
    Bakhtiar R; Tse FL
    Biomed Chromatogr; 2004 Jun; 18(5):275-81. PubMed ID: 15236434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)-threo and (±)-erythro diastereomers.
    McLaughlin G; Morris N; Kavanagh PV; Power JD; Dowling G; Twamley B; O'Brien J; Hessman G; Murphy B; Walther D; Partilla JS; Baumann MH; Brandt SD
    Drug Test Anal; 2017 Mar; 9(3):347-357. PubMed ID: 28103426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability.
    Markowitz JS; Zhu HJ; Patrick KS
    J Child Adolesc Psychopharmacol; 2013 Dec; 23(10):648-54. PubMed ID: 24261661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration.
    Ding YS; Gatley SJ; Thanos PK; Shea C; Garza V; Xu Y; Carter P; King P; Warner D; Taintor NB; Park DJ; Pyatt B; Fowler JS; Volkow ND
    Synapse; 2004 Sep; 53(3):168-75. PubMed ID: 15236349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
    Davids E; Zhang K; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):92-8. PubMed ID: 11862378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurobehavioral effects of racemic threo-methylphenidate and its D and L enantiomers in rats.
    Teo SK; Stirling DI; Thomas SD; Khetani VD
    Pharmacol Biochem Behav; 2003 Feb; 74(3):747-54. PubMed ID: 12543241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor.
    Markowitz JS; DeVane CL; Ramamoorthy S; Zhu HJ
    Pharmazie; 2009 Feb; 64(2):123-5. PubMed ID: 19322953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
    Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in plasma concentrations of the D- and L-threo methylphenidate enantiomers in responding and non-responding children with attention-deficit hyperactivity disorder.
    Jonkman LM; Verbaten MN; de Boer D; Maes RA; Buitelaar JK; Kemner C; van Engeland H; Koelega HS
    Psychiatry Res; 1998 Mar; 78(1-2):115-8. PubMed ID: 9579707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
    Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatographic and electrophoretic strategies for the chiral separation and quantification of d- and l-threo methylphenidate in biological matrices.
    Allen SA; Pond BB
    Biomed Chromatogr; 2014 Nov; 28(11):1554-64. PubMed ID: 25196779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-methylphenidate and D,L-methylphenidate are not developmental toxicants in rats and rabbits.
    Teo SK; Stirling DI; Hoberman AM; Christian MS; Thomas SD; Khetani VD
    Birth Defects Res B Dev Reprod Toxicol; 2003 Apr; 68(2):162-71. PubMed ID: 12866707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.